AstraZeneca shares fall 8.9% over merger talks with US cancer drug firm
News Source
•Mon, 03 Aug 2026 16:32:09 GMT
📰 What Happened
AstraZeneca shares plunged 8.9% after news broke that the company was in merger talks with Bristol Myers Squibb. Over £17 billion was wiped off the company's value in a single day. AstraZeneca lost its spot as the UK's second-largest listed company to Shell. Bristol Myers Squibb shares rose 1.7% initially but later fell back. The proposed deal would be one of the biggest pharmaceutical mergers ever, worth nearly $400 billion.
🔍 The Backstory
Investors were spooked because big pharma mergers often fail to deliver promised savings. AstraZeneca had been a stock market darling under CEO Pascal Soriot, rising consistently for years. The company developed a successful COVID-19 vaccine and has a strong pipeline of cancer drugs. Analysts say a merger of this size would be extremely difficult to pull off. There is no guarantee the deal will happen, and talks could still fall apart.
🎯 Why It Matters
The stock drop shows that even successful companies can lose billions in value quickly. If you own shares through a pension or investment fund, big deals like this can affect your savings.
AstraZeneca shares plunged 8.9% after news broke that the company was in merger talks with Bristol Myers Squibb. Over £17 billion was wiped off the company's value in a single day. AstraZeneca lost its spot as the UK's second-largest listed company to Shell. Bristol Myers Squibb shares rose 1.7% initially but later fell back. The proposed deal would be one of the biggest pharmaceutical mergers ever, worth nearly $400 billion.
Investors were spooked because big pharma mergers often fail to deliver promised savings. AstraZeneca had been a stock market darling under CEO Pascal Soriot, rising consistently for years. The company developed a successful COVID-19 vaccine and has a strong pipeline of cancer drugs. Analysts say a merger of this size would be extremely difficult to pull off. There is no guarantee the deal will happen, and talks could still fall apart.
The stock drop shows that even successful companies can lose billions in value quickly. If you own shares through a pension or investment fund, big deals like this can affect your savings.